Literature DB >> 8755565

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

M Bacher1, C N Metz, T Calandra, K Mayer, J Chesney, M Lohoff, D Gemsa, T Donnelly, R Bucala.   

Abstract

The protein known as macrophage migration inhibitory factor (MIF) was one of the first cytokines to be discovered and was described 30 years ago to be a T-cell-derived factor that inhibited the random migration of macrophages in vitro. A much broader role for MIF has emerged recently as a result of studies that have demonstrated it to be released from the anterior pituitary gland in vivo. MIF also is the first protein that has been identified to be secreted from monocytes/macrophages upon glucocorticoid stimulation. Once released, MIF acts to "override" or counter-regulate the suppressive effects of glucocorticoids on macrophage cytokine production. We report herein that MIF plays an important regulatory role in the activation of T cells induced by mitogenic or antigenic stimuli. Activated T cells produce MIF and neutralizing anti-MIF antibodies inhibit T-cell proliferation and interleukin 2 production in vitro, and suppress antigen-driven T-cell activation and antibody production in vivo. T cells also release MIF in response to glucocorticoid stimulation and MIF acts to override glucocorticoid inhibition of T-cell proliferation and interleukin 2 and interferon gamma production. These studies indicate that MIF acts in concert with glucocorticoids to control T-cell activation and assign a previously unsuspected but critical role for MIF in antigen-specific immune responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755565      PMCID: PMC38837          DOI: 10.1073/pnas.93.15.7849

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Diversity of cytokine synthesis and function of mouse CD4+ T cells.

Authors:  T R Mosmann; J H Schumacher; N F Street; R Budd; A O'Garra; T A Fong; M W Bond; K W Moore; A Sher; D F Fiorentino
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

Review 2.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor.

Authors:  E Schmitt; R Van Brandwijk; J Van Snick; B Siebold; E Rüde
Journal:  Eur J Immunol       Date:  1989-11       Impact factor: 5.532

4.  Polyclonal B-cell stimulation by L3T4+ T cells in experimental leishmaniasis.

Authors:  M Lohoff; C Matzner; M Röllinghoff
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

5.  Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).

Authors:  J Bernhagen; R A Mitchell; T Calandra; W Voelter; A Cerami; R Bucala
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

6.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

7.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

8.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

Authors:  R I Scheinman; P C Cogswell; A K Lofquist; A S Baldwin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

9.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

Authors:  N Auphan; J A DiDonato; C Rosette; A Helmberg; M Karin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  200 in total

1.  Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes.

Authors:  Chao Tong; Alex Morrison; Xiaoyan Yan; Peng Zhao; Eddie D Yeung; Jingying Wang; Jianxin Xie; Ji Li
Journal:  J Diabetes       Date:  2010-12       Impact factor: 4.006

2.  Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  Y Mitamura; S Takeuchi; A Matsuda; Y Tagawa; Y Mizue; J Nishihira
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

4.  Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis.

Authors:  N Kitaichi; S Kotake; Y Mizue; H Matsuda; K Onoé; J Nishihira
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

5.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

6.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 7.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

Review 8.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

9.  Ostertagia ostertagi macrophage migration inhibitory factor is present in all developmental stages and may cross-regulate host functions through interaction with the host receptor.

Authors:  Guanggang Qu; Raymond Fetterer; Lin Leng; Xin Du; Dante Zarlenga; Zhiqiang Shen; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

Review 10.  Emerging Systemic Therapies for Colorectal Cancer.

Authors:  Christine M Veenstra; John C Krauss
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.